Molecular remission and response patterns in patients with mutant-IDH2 acute myeloid leukemia treated with enasidenib. (2019)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1182/blood-2018-08-869008
PubMed Identifier: 30510081
Publication URI: http://europepmc.org/abstract/MED/30510081
Type: Journal Article/Review
Volume: 133
Parent Publication: Blood
Issue: 7
ISSN: 0006-4971